Role of miR-125b and miR-203 expressions in the pathogenesis of BCR-ABL+ Acute Lymphoblastic Leukemia (ALL)
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Gene Reports
- Vol. 4, 253-257
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Morphology of Blood Disorders2014
- Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaFrontiers in Oncology, 2014
- DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIAMediterranean Journal of Hematology and Infectious Diseases, 2014
- MicroRNA‐203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivinFEBS Letters, 2012
- Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north IndiaIndian Journal of Medical Research, 2012
- MicroRNA miR-125b causes leukemiaProceedings of the National Academy of Sciences, 2010
- Pattern of Relapse in Childhood ALL: Challenges and Lessons From a Uniform Treatment ProtocolJournal of Pediatric Hematology/Oncology, 2010
- Epidemiology of childhood cancer in IndiaIndian Journal of Cancer, 2009
- Treatment of children with acute lymphoblastic leukemia in India using a BFM protocolPediatric Blood & Cancer, 2008
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene ExpressionCancer Cell, 2008